Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1295689

NC/C(=C/Cl)CCc1ccc(F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC2 O75106 1/20 0.57
MAOA P21397 1/20 0.57
MAOB P27338 1/20 0.57
AOC3 Q16853 1/20 0.57
FFAR1 O14842 3/20 0.46
TAAR1 Q96RJ0 1/20 0.39
GRM2 Q14416 1/20 0.39
GRM3 Q14832 1/20 0.39
PLAAT3 P53816 1/20 0.38
PLAAT5 Q96KN8 1/20 0.38
PLAAT2 Q9NWW9 1/20 0.38
PLAAT4 Q9UL19 1/20 0.38
P2RX7 Q99572 1/20 0.38
SLC5A1 P13866 1/20 0.38
SLC5A2 P31639 1/20 0.38
LMNA P02545 2/20 0.36
S1PR1 P21453 1/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1295425 1.00 AOC2 (0.57) AOC2MAOAMAOBAOC3FFAR1
Trifluoroacetic Acid SCHEMBL1295432 1.00 AOC2 (0.57) AOC2MAOAMAOBAOC3FFAR1
Trifluoroacetic Acid SCHEMBL1295756 0.89 AOC2 (0.43) AOC2MAOAMAOBAOC3FFAR1
Trifluoroacetic Acid SCHEMBL1295216 0.89 AOC2 (0.43) AOC2MAOAMAOBAOC3FFAR1
Trifluoroacetic Acid SCHEMBL1295212 0.89 AOC2 (0.43) AOC2MAOAMAOBAOC3FFAR1
SCHEMBL1295015 0.88 MAOB (0.72) AOC2MAOAMAOBAOC3FFAR1
SCHEMBL1295016 0.88 MAOB (0.72) AOC2MAOAMAOBAOC3FFAR1
SCHEMBL1295522 0.88 MAOB (0.72) AOC2MAOAMAOBAOC3FFAR1
Trifluoroacetic Acid SCHEMBL1295907 0.81 FFAR1 (0.51) AOC2MAOAMAOBAOC3FFAR1
Trifluoroacetic Acid SCHEMBL1295071 0.81 RXRA (0.37) AOC2MAOAMAOBAOC3FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269811-A1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES FASTRACK PHARMACEUTICALS, INC. 2011-11-03 US disclosed
US-20090203764-A1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES FASTRACK PHARMACEUTICALS, INC. 2009-08-13 US disclosed
US-20070293548-A1 Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases LA JOLLA PHARMACEUTICAL COMPANY 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293548-A1 Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases VCAM1, AOC3, AOC2 AOC2 3/4885MAOA 41/4885MAOB 56/4885
US-20110269811-A1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES VCAM1, AOC3, AOC2 AOC2 3/4885MAOA 41/4885MAOB 56/4885
US-20090203764-A1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES VCAM1, AOC3, AOC2 AOC2 3/4885MAOA 41/4885MAOB 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.